๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel

โœ Scribed by Roberto Petrioli; Alessandra Pascucci; Edoardo Francini; Stefania Marsili; Angela Sciandivasci; Giovanni De Rubertis; Gabriele Barbanti; Antonio Manganelli; Francesco Salvestrini; Guido Francini

Book ID
109053383
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
85 KB
Volume
100
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase 2 study of carboplatin plus doce
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
โœ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, secondโ€line therapy for docetaxelโ€refractory disease. Recent data suggest that platinum salts may be effective when combined wi

Intermittent chemotherapy in patients wi
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer : Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel
โœ Tomasz M. Beer; Christopher W. Ryan; Peter M. Venner; Daniel P. Petrylak; Gurkam ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. Survival in patients with metastatic, chemotherapyโ€naive, androgenโ€independent prostate cancer (AIPC) is improved with 10 to 12 cycles of docetaxelโ€containing chemotherapy but further management is undefined. In the current study, the authors examined retreatment with th